New diagnosis for hepatocellular carcinoma via hsa_circ_0097009
Preprint
- 4 November 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Although circular RNAs take a key part in the regulation of cancer, its role in the diagnosis and prognosis of hepatocellular carcinoma (HCC) still unclear. This study investigated the diagnostic and prognostic usefulness of hsa_circ_0097009 in HCC. Methods qRT-PCR assay was performed to detect the presence of hsa_circ_0097009 in plasma collected from 30 HCC patients and 30 healthy controls. Receiver operating characteristic (ROC) curve, Cox regression, and Kaplan–Meier curve analyses were applied to evaluate the clinical diagnostic and prognostic values of hsa_circ_0097009. Results The experimental data suggested that hsa_circ_0097009 expression of HCC plasma and cell lines is upregulated. The plasma hsa_circ_0097009 level of HCC patients was linked to tumor diameter (P = 0.026) and alpha-fetoprotein (AFP) expression level (P = 0.019). In addition, the plasma level of hsa_circ_0097009 decreased markedly after surgery to remove the tumor. Moreover, the level of plasma of hsa_circ_0097009 in HCC patients was increased compared with healthy controls (P < 0.0001) and hepatitis B patients. ROC curve reflected that the area under the curve (AUC) of plasma hsa_circ_0097009 to distinguish HCC from healthy controls and hepatitis B patients were 0.9368 (95 percent CI = 0.8874–0.9862) and 0.9067 (95 percent CI = 0.8439–0.9695), respectively, with the same sensitivity 0.9779 and the same specificity 0.6889. Furthermore, the AUC value of hsa_circ_0097009 combined with AFP for distinguishing HCC from healthy controls was 0.9822 (95 percent CI = 0.9682–0.9961), with the sensitivity 0.9889 and specificity 0.667. The plasma hsa_circ_0097009 low expression group had a considerably longer overall survival (OS) than the high expression group. Conclusion The study suggests that hsa_circ_0097009 could be used as a new potential biomarker in diagnoses and prognoses of HCC patients.Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- Circulating circular RNA hsa_circ_0001785 acts as a diagnostic biomarker for breast cancer detectionClinica Chimica Acta, 2018
- circRNAs in CancerCurrent Opinion in Genetics & Development, 2018
- Biomarker development for hepatocellular carcinoma early detection: current and future perspectivesHepatic Oncology, 2017
- Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patientsTumor Biology, 2017
- CircRNA: functions and properties of a novel potential biomarker for cancerMolecular Cancer, 2017
- Decreased expression of hsa_circ_0001895 in human gastric cancer and its clinical significancesTumor Biology, 2017
- Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically ExpressedMolecular Cell, 2015
- Systemic treatment of advanced hepatocellular carcinoma: From disillusions to new horizonsEuropean Journal of Cancer, 2015
- Cancer survival in China, 2003–2005: A population‐based studyInternational Journal of Cancer, 2014
- Circular RNAs are a large class of animal RNAs with regulatory potencyNature, 2013